1. The novel surfactant protein SP-H enhances the phagocytosis efficiency of macrophage-like cell lines U937 and MH-S.
- Author
-
Diler E, Schicht M, Rabung A, Tschernig T, Meier C, Rausch F, Garreis F, Bräuer L, and Paulsen F
- Subjects
- Animals, Cell Line, Dose-Response Relationship, Drug, Fluorescence, Humans, Lymphocytes cytology, Lymphocytes immunology, Macrophages, Alveolar cytology, Macrophages, Alveolar immunology, Mice, Microspheres, Organ Specificity, Species Specificity, Lymphocytes drug effects, Macrophages, Alveolar drug effects, Phagocytosis, Pulmonary Surfactant-Associated Proteins pharmacology
- Abstract
Background: Surfactant proteins (SP) secreted by alveolar type 2 cells, play an essential role in maintaining the air-liquid barrier of the lung and are also involved in the opsonisation and clearance of bacteria by phagocytes. We have recently described a novel surfactant protein, SP-H (SFTA3). Expression of SP-H was earlier demonstrated to be upregulated by LPS and negatively regulated by IL-1β and IL-23 in vitro. The influence of SP-H on phagocytosis was measured using a murine and a human phagocytic cell line and fluorescent latex beads., Findings: SP-H markedly increases phagocytosis in vitro in the murine-derived alveolar macrophage cell lines MH-S and in human-derived differentiated U937 cells., Conclusion: It can be assumed that SP-H is involved in regulating phagocytic activity of macrophages. SP-H is a new player in pulmonary host defence.
- Published
- 2014
- Full Text
- View/download PDF